This multicenter , double-blind , two-period , cross-over study randomized healthy , Chinese women 18 years of age to etoricoxib 120mg qd or ibuprofen up to 2400mg ( 600mg qid ) upon onset of moderate or severe primary dysmenorrhea symptoms during two menstrual cycles .